🇺🇸 FDA
Patent

US 9234016

Engineered zinc finger proteins for treating trinucleotide repeat disorders

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 9234016 (Engineered zinc finger proteins for treating trinucleotide repeat disorders) held by Sangamo Biosciences, Inc. expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00, A61P